We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$9.35B
AUM Growth
+$149M
Cap. Flow
-$135M
Cap. Flow %
-1.45%
Top 10 Hldgs %
16.19%
Holding
2,678
New
110
Increased
434
Reduced
834
Closed
256

Sector Composition

Rank Sector Weight
1 Technology 16.75%
2 Financials 14.99%
3 Healthcare 13.12%
4 Industrials 10.24%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFE
1626
Safehold
SAFE
$1.09B
$390K ﹤0.01%
6,449
MBI icon
1627
MBIA
MBI
$254M
$390K ﹤0.01%
41,874
NTUS
1628
DELISTED
Natus Medical Inc
NTUS
$389K ﹤0.01%
15,157
MDGL icon
1629
Madrigal Pharmaceuticals
MDGL
$12.4B
$386K ﹤0.01%
3,687
+564
+18% +$60.4K
ACCO icon
1630
Acco Brands
ACCO
$399M
$385K ﹤0.01%
48,975
SSP icon
1631
E.W. Scripps
SSP
$310M
$385K ﹤0.01%
25,176
+3,551
+16% +$66.4K
NRC icon
1632
NRC Health Common Stock
NRC
$471M
$385K ﹤0.01%
6,681
+1,731
+35% +$80.1K
SYBT icon
1633
Stock Yards Bancorp
SYBT
$2.64B
$384K ﹤0.01%
10,633
AMPH icon
1634
Amphastar Pharmaceuticals
AMPH
$858M
$384K ﹤0.01%
18,205
QNST icon
1635
QuinStreet
QNST
$1.19B
$382K ﹤0.01%
24,131
+6,046
+33% +$90.3K
MMI icon
1636
Marcus & Millichap
MMI
$1.18B
$382K ﹤0.01%
12,368
+3,133
+34% +$114K
FOCS
1637
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$381K ﹤0.01%
13,966
+2,148
+18% +$70K
MGNX icon
1638
MacroGenics
MGNX
$259M
$381K ﹤0.01%
22,474
+3,813
+20% +$65.5K
ALX
1639
Alexander's
ALX
$1.39B
$381K ﹤0.01%
1,029
HOUS
1640
DELISTED
Anywhere Real Estate
HOUS
$380K ﹤0.01%
52,555
-16,629
-24% -$155K
CCF
1641
DELISTED
Chase Corporation
CCF
$380K ﹤0.01%
3,533
EVRI
1642
DELISTED
Everi Holdings
EVRI
$380K ﹤0.01%
31,818
WT icon
1643
WisdomTree
WT
$3.44B
$379K ﹤0.01%
61,432
+7,744
+14% +$52.6K
CKH
1644
DELISTED
Seacor Holdings Inc.
CKH
$379K ﹤0.01%
7,977
NXRT
1645
NexPoint Residential Trust
NXRT
$631M
$379K ﹤0.01%
9,154
ATRA icon
1646
Atara Biotherapeutics
ATRA
$83.1M
$379K ﹤0.01%
753
TVTX icon
1647
Travere Therapeutics
TVTX
$5.79B
$379K ﹤0.01%
18,842
OSG
1648
Octave Specialty Group
OSG
$210M
$378K ﹤0.01%
22,444
QUOT
1649
DELISTED
Quotient Technology Inc
QUOT
$378K ﹤0.01%
35,202
LNN icon
1650
Lindsay Corp
LNN
$1.18B
$378K ﹤0.01%
4,595

Similar funds

MetLife Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, MetLife Investment Management held 2,678 positions worth $9.35B, up 1.6% from $9.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q2 2019 filing shows 110 new, 434 increased, 834 reduced and 256 closed positions. Its largest new stake was Dow Inc: 206,405 shares worth $10.2M. The largest sale was Apple, an estimated $13.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2019 buy was Dow Inc: 206,405 shares worth $10.2M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $62.7M increase.
  • MetLife Investment Management's biggest Q2 2019 reduction was Apple, cutting an estimated $13.4M.
  • MetLife Investment Management fully exited iShares National Muni Bond ETF in Q2 2019, selling an estimated $12.8M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.35B portfolio in Q2 2019.
  • MetLife Investment Management opened 110 new positions and closed 256 in Q2 2019.
  • MetLife Investment Management's portfolio value rose 1.6% quarter-over-quarter to $9.35B.

Based on MetLife Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.